Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
P 2 (1)
P 4 (1)

Trial Status

Unknown2
Recruiting2

Clinical Trials (4)

Showing 4 of 4 trials
NCT05305287Phase 4Recruiting

Quantifying Hepatic Mitochondrial Fluxes in Humans

NCT04802707Phase 2Recruiting

Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome

NCT03179137Unknown

Mitochondrial Bioenergetics and Role in Cellular Damage in Ischemic Myocardium

NCT03111719UnknownPrimary

Human Brown Adipose Tissue and Mitochondrial Respiration

Showing all 4 trials

Research Network

Activity Timeline